New York State Common Retirement Fund’s The Oncology Institute TOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97.2K Buy
17,900
+12,300
+220% +$51.7K ﹤0.01% 2709
2026
Q1
$17.2K Hold
5,600
﹤0.01% 3030
2025
Q4
$19.9K Hold
5,600
﹤0.01% 3089
2025
Q3
$19.5K Sell
5,600
-39,100
-87% -$134K ﹤0.01% 3111
2025
Q2
$91.6K Buy
+44,700
New +$112K ﹤0.01% 2739
2023
Q3
Sell
-309
Closed -$170 3369
2023
Q2
$170 Sell
309
-10,800
-97% -$5.71K ﹤0.01% 3405
2023
Q1
$7.53K Hold
11,109
﹤0.01% 3188
2022
Q4
$18.3K Buy
11,109
+135
+1% +$379 ﹤0.01% 3189
2022
Q3
$51K Sell
10,974
-4,826
-31% -$28.4K ﹤0.01% 3136
2022
Q2
$80K Buy
+15,800
New +$115K ﹤0.01% 3149

Other funds holding TOI

New York State Common Retirement Fund's TOI Position: Q2 2026 in Review

New York State Common Retirement Fund increased its The Oncology Institute (TOI) stake by 220% in Q2 2026, buying an estimated $51.7K and bringing the position to 17,900 shares worth $97.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2709.

New York State Common Retirement Fund first reported a position in TOI in Q2 2022 and has held it in 10 quarters since. 19 funds tracked by Wall St. Rank hold TOI as of Q2 2026.

  • New York State Common Retirement Fund held 17,900 shares of The Oncology Institute worth $97.2K as of Q2 2026.
  • New York State Common Retirement Fund bought 12,300 The Oncology Institute shares in Q2 2026, an estimated $51.7K.
  • The Oncology Institute made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2709 holding.
  • New York State Common Retirement Fund first reported a position in The Oncology Institute in Q2 2022 and has held it in 10 quarters since.
  • 19 funds tracked by Wall St. Rank held The Oncology Institute as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.